We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBC icon
476
Eastern Bankshares
EBC
$5.26B
$430K 0.07%
+21,907
New +$438K
IPAR icon
477
Interparfums
IPAR
$3.99B
$429K 0.06%
+5,681
New +$450K
FTNT icon
478
Fortinet
FTNT
$119B
$428K 0.06%
8,721
-40,817
-82% -$2.21M
MODN
479
DELISTED
MODEL N, INC.
MODN
$427K 0.06%
12,483
-6,386
-34% -$185K
CELL
480
DELISTED
PhenomeX Inc. Common Stock
CELL
$427K 0.06%
149,413
-121,127
-45% -$515K
ACIW icon
481
ACI Worldwide
ACIW
$5.83B
$425K 0.06%
20,338
-9,921
-33% -$247K
MDGL icon
482
Madrigal Pharmaceuticals
MDGL
$10.8B
$424K 0.06%
6,524
+1,955
+43% +$136K
INGR icon
483
Ingredion
INGR
$6.27B
$422K 0.06%
+5,243
New +$460K
COR icon
484
Cencora
COR
$60.6B
$421K 0.06%
+3,109
New +$446K
LULU icon
485
lululemon athletica
LULU
$13.5B
$420K 0.06%
+1,503
New +$466K
WRB icon
486
W.R. Berkley
WRB
$26.9B
$420K 0.06%
9,759
-9,048
-48% -$393K
CACI icon
487
CACI
CACI
$11B
$415K 0.06%
+1,591
New +$448K
KALU icon
488
Kaiser Aluminum
KALU
$2.61B
$415K 0.06%
+6,772
New +$498K
STRO icon
489
Sutro Biopharma
STRO
$401M
$414K 0.06%
7,466
-3,726
-33% -$221K
SM icon
490
SM Energy
SM
$7.8B
$413K 0.06%
+10,974
New +$432K
ACM icon
491
Aecom
ACM
$9.3B
$409K 0.06%
5,979
-5,135
-46% -$364K
KRUS icon
492
Kura Sushi USA
KRUS
$560M
$407K 0.06%
+5,538
New +$427K
NTB icon
493
Bank of N.T. Butterfield & Son
NTB
$2.43B
$406K 0.06%
12,521
-11,624
-48% -$386K
HCP
494
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$406K 0.06%
+12,623
New +$436K
MMM icon
495
3M
MMM
$90.9B
$403K 0.06%
4,365
-1,544
-26% -$169K
SUM
496
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$403K 0.06%
+17,120
New +$460K
MHO icon
497
M/I Homes
MHO
$3.74B
$395K 0.06%
10,898
-15,918
-59% -$687K
OLED icon
498
Universal Display
OLED
$3.75B
$395K 0.06%
4,184
-6,725
-62% -$744K
ITT icon
499
ITT
ITT
$17.5B
$394K 0.06%
+6,027
New +$439K
TMCI icon
500
Treace Medical Concepts
TMCI
$280M
$394K 0.06%
17,840
-6,880
-28% -$133K

Similar funds

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.